Department of Biotechnology
Ministry of S & T   
Department of Pharmaceuticals   

   

   

   

   

   

   

   

   

   

   

Co-Chair
Dr. Martin Mackay, President Global R&D Pfizer
Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd
Dr. Naresh Trehan, Chairman MediCity
Jeff Elton, Life Sciences Investor & Consultant

Advisory Board
Dr. Barry Bloom, Harvard University Distinguished Service Professor & Past Dean Harvard School of Public Health
George Bickerstaff, Managing Director, CRT Capital Group
William W.Chin,M.D., Vice President Discovery Research, Eli Lilly & Company
Venkat Jasti, Chairman & CEO, Suven Lifesciences
Dr. Ismail Kola, Sr. Vice President & CSO, Schering Plough
Reid Leonard, Executive Director, Merck & Co.
Dr. Peter Mueller, Executive Vice President & CSO, Vertex Pharmaceuticals
CSN Murthy, CEO, Aurigene Discovery
Dr. Michael Rosenblatt, Dean, Tufts University School of Medicine
Dr. K.V. Subramaniam, CEO, Reliance Life Sciences
Dr. Sridaran Natesan, PhD, Co-Leader - Stem Cell Initiative, Sanofi-avntis
Dr. Gunther Winkler, Sr. Vice President, Biogen Idec

Program Schedule (Program & Timings subject to change)

The program started with the guests' Registration. Karun Rishi, President-USA-India Chamber of Commerce, welcomed guests and gave opening remarks.

Dr. Martin Mackay released the Annual Position Paper commissioned by USAIC. McKinsey & Company presented ths USA-India Chamber of Commerce commissioned annual Position Paper. This was followed by the panel discussion on Healthcare, Clinical Research and Industry-Academic Partnerships
Panelists :  Dr. Gerald Keusch, Associate Provost, BU School of Public Health, Dr. David Lacey, Senior Vice President & Head of Research, Amgen, Dr. Michael Rosenlatt, Dean Tufts University School of Medicine, Joe Smith, MD, PhD, Vice President-Emerging Technologies, Johnson & Johnson, Sridhar Mosur, Chief Executive Officer, Jubilant Biosys
Moderator: Dr. William Chin, Vice President - Discovery Research & Clinical Investigation, Eli Lilly & Company

Manni Kanti Pudi, President, GVK BioSciences presented the Introduction

Martin Mackay, President, Pfizer Global Research & Development gave the Keynote Address.

Panel Discussion: Funding Innovation, Cross Border Investment and M&A Trends
Panelists:  K.V.Subramaniam, President & CEO, Reliance Life Sciences; Jeff Collins, Executive in Residence, Pappas Ventures; Jeffrey Elton, Life Sciences Investor & Consultant; George Bickerstaff, Managing Director, CRT Investment Banking; Shrikumar Suryanarayan, Director General, ABLE
Moderator: Glen Giovanneti, Global Biotechnology Leader, Ernst & Young

Introduction: Banashri Bose Harrison, Minister (Commerce), Embassy of India

Networking and Tea Break

Keynote Address by Nobel Laureate Dr. Sidney Altman

Presentation by Department of Pharmaceuticals, Govt of India. Paresh Johri, Deputy Secretary

Panel Discussion: Drug discovery, Development and Collaborative Research
Panelists:  Robert Armstrong, PhD, Vice President, Global External R&D, Eli Lilly; Venkat Jasti, Chairman & CEO, Suven Life Sciences; Ismail Kola, PhD, Senior Vice President- Discovery Research & Chief Scientific Officer, Schering-Plough; CSN Murthy, Chief Executive Officer, Aurigene Discovery; Dr. John Thompson, Vice President, Strategic Research Alliances, Vertex

Moderator: Ramesh Srinivasan, Principal, McKinsey and Company

Introduction: Reid Leonard, PhD, Executive Director, External Research & Licensing, Merck & Co.

Honoring Dr. Barry R. Bloom

Introduction by Dr. Gerald Keusch, Associate Provost, BU School of Public Health

Award Presentation by Dr. Martin Mackay and Karun Rishi

Address by Dr. Barry R. Bloom, Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health at the Department of Immunology and Infectious Diseases, Harvard School of Public Health

Closing Remarks - James Mullen President & CEO, Biogen Idec 

Cocktails and Networking Reception - Charles View Ballroom, 16^th Floor

Highlights

• Annual high profile summit of established and emerging Biotech, Pharmaceuticals, Medical Devices, Healthcare companies form the US and India, Venture Capitalists, Investment Bankers, Policy Makers and Academia
• Release of USA India Chamber of Commerce commissioned McKinsey & Company Position Paper. See 2008 Summit details
• THE Bio Pharma event in the world focused on US-India BioPharma, Medical Devices and Healthcare
• Access to key people focused on US-India BioPharma & Healthcare and top tier investors
• An ideal opportunity to enhance corporate visibility to people who matter
• Large participation by CEOs, Chief Scientific Officers and Chief Medical Officers of large and emerging Bio, Pharma, Medical Devices and Healthcare companies
• Participation by senior partners of top tier Life Sciences/Healthcare Venture Capitalist, Investment Bankers and Private Equity firms
• A forum open only to senior executives

Department of Biotechnology
Ministry of Science & Technology
Government of India























:

1-30 PM - 2-00 PM: Registration
Master of Ceremonies: Hon. Andrew Maguire, PhD, Executive Director-GAVI

2-00 PM - 2-10 PM: Welcome address and opening remarks by Karun Rishi, President USA-India Chamber of Commerce

2-10 PM Â- 2-30 PM: McKinsey & Company presentation of USA-India Chamber of Commerce annual Position Paper

2-35 PM Â- 3-25 PM: Panel Discussion:
Drug Discovery, Collaborative Research and Strategic Alliances

Panelists:
    Dr. William Chin, Vice President - Discovery Research, Eli Lilly
    Venkat Jasti, Vice Chairman & CEO, Suven Life Sciences
    Dr. Peter Mueller, Exe. Vice President & CSO, Vertex Pharmaceuticals
    Barbara Yanni, Chief Licensing Officer, Merck & Co.
    Dr. Rashmi Barbhaiya, Co-Founder and CEO, Advinus Therapeutics
3-30 PM - 3-55 PM: Official Release of Position Paper and Keynote address by Honorable Kapil Sibal, Minister of Science & Technology and Earth Sciences, Government of India *
3-55 PM Â- 4-25 PM: Networking and Tea Break
4-25 PM Â- 5-15 PM: Panel Discussion:
Funding Innovation, Investment Opportunities, Cross Border M&A trends

Panelists:
    Frederick Frank, Vice Chairman & Director, Lehman Brothers
    Dr. Helmut M. Schühsler, Managing Partner, TVM Capital
    Tom Andrews, Senior Vice President, Alexandria Real Estate Equities
    Sri Mosur, President & CEO, Jubilant Biosys Ltd.
    Dr. Jasmin Patel, Managing Director, Fidelity Capital Management (India)
5-15 PM - 5-40 PM: Keynote address by Dr. Surinder Singh, Drug Controller General of India *
5-40 PM - 6-00 PM: Introduction: James Mullen, President & CEO, Biogen Idec and past Chairman, Biotechnology Industry Organization (BIO)

Keynote address by Dr. Joshua Boger, President & CEO, Vertex Pharmaceuticals and Chairman, Biotechnology Industry Organization (BIO)
6-00 PM Â- 6-50 PM: Panel Discussion:
Drug Development & Manufacturing, Clinical Research and In/Out Licensing
Panelists:
    Dr. Mark Powell, Sr VP & Worldwide Head-Pharmaceutical Development, Bristol Myers & Squibb
    Gregg Alton, Senior Vice President, Gilead Sciences
    Dr. Gunther Winkler, Sr. Vice President, Biogen Idec
    Dr. Arun Chandavarkar, Chief Operating Officer, Biocon Ltd.
    Dr. Dianne Kikta, Vice President Global Clinical, Wyeth
    Dr. Sreeni Devidas, Vice President, GVK BioSciences
6-50 PM - 7-00 PM: Closing Remarks
Dr. Helmut M. Schühsler, Managing Partner, TVM Capital and Board Member, USA-India Chamber of Commerce
7-00 PM - 8-30 PM: Cocktails and Networking Reception
                             Charles View Ballroom, 16^th Floor

     Media Partners
               
 

Department of Biotechnology
Ministry of Science & Technology
Government of India

2007 Summit details
5-00 pm Â- 5-15 pm: Registration

5-15 pm Â- 5-30 pm: Summit inauguration and remarks by James C. Mullen, Chairman Biotechnology Industry Organization (BIO), CEO & President, Biogen Idec
5-30 pm Â- 5-45 pm:

   Welcome address and opening remarks by
   Karun Rishi, President, USA-India Chamber of Commerce
Release of USA-India Chamber of Commerce-Ernst & Young Position Paper on Indian Biotech industry 5-45 pm - 6-30 pm: Panel Discussion (1):

Discovery, Development, IP & Regulatory Issues
Panelists:
   Dr. Alan Smith, Chief Scientific Officer, Genzyme
   Dr. Peter Mueller, Chief Scientific Officer, Vertex Pharmaceuticals
   Dr. Rashmi H.Barbhaiya, CEO and MD, Advinus Therapeutics
   Dr. Sridhar Mosur, Managing Director, Jubilant Chemsys Ltd
   Dr. Arun Chandavarkar, Chief Operating Officer, Biocon Ltd.

Moderator:
   David C U'Prichard, PhD,
   Partner, Red Abbey Venture Partners and Care Capital

6-30 pm Â- 6-45 pm Keynote Address:
   Dr.M.K.Bhan, Secretary-Govt of India, Dept of Biotechnology
   Introduction to Dr. MK Bhan by Joel Marcus,
   CEO of Alexandria Real Estate Equities

6-45 pm - 7-30 pm: Panel Discussion (2):
   Investment Opportunities, Cross Border Investments, and
   M&A Trends in the Life Sciences industry (US-India)

Panelists:
   Dr. Helmut M. Schühsler, Managing Partner, TVM Capital
   Dr. David Gluckman, MD & Head of European Life Sciences, Lazard
   George Bickerstaff, Managing Director, CRT Capital Group
   Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd
   Dr. Stephen Knight, Managing Partner, Fidelity Biosciences

Moderator:
   Utkarsh Palnitkar , Partner-Transaction Advisory Services,
   Industry Leader - Health Sciences, Ernst & Young

Closing remarks: Dr. Helmut M. Schühsler, Managing Partner, TVM Capital and Board Member, USA-India Chamber of Commerce

7-30 pm- 9 pm: Cocktails & Networking Reception

Media Partners
                 

April 12, 2007           Agenda & Registration
Location: The Westin New York at Times Square
USA-India Camber of Commerce is the Association Partner of BRIC Symposium. USAIC members save 15% off the The Deal's BRICs Symposium.

M&A and Investment opportunities in key emerging economies continue to thrill and terrify US professionals. In this one-day symposium, an audience of bankers, strategic acquirers, private equity partners and other alternative investment will gather in New York to hear the strategies and perspective of the leading investors and dealmakers who are having significant success currently in Brazil, Russia, India and China (BRIC).

 

Special focus on opportunities for US SME companies in India. The two day conference besides several keynotes will have sessions on IT, ITeS, Retail, Real Estate, Food Processing, Auto and Auto Components, Financing, Entrepreneurship, Policy, Market Access, Emerging sectors and Export opportunities.

Senior policy makers and key executives from Walmart, Citigroup, Bank of America, SBA, Coca-Cola, Kelloggs, Tishman Spyer, Parsons, IBM, Hero Group, UPS, Bharti, General Motors, EXIM Bank, and Proctor & Gamble etc will participate in the panel discussions.

Place: Maurya Sheraton Hotel, New Delhi, India

Date: Jan 23-25, 2007

Prof Reddy was recently appointed President of the Public Health Foundation of India. Dr. Reddy Chairs numerous healthcare commissions and committees in India and internationally.

Exciting things are happening in IndiaÂ’s healthcare sector. Industry, Academia, Research institutions and Investors in the US need to take a serious look at India opportunity. This roundtable is only for senior executives.

Event is complementary for members.

USA-India Chamber of Commerce is pleased to support the Business Development Mission led by Amb. Franklin L. Lavin, Under Secretary for International Trade, U.S. Department of Commerce. This precedent-setting initiative, potentially involving the largest ever overseas delegation of its kind led by a U.S. Government official, will serve as the capstone of a year of successful activities conducted under the auspices of the U.S.-India Commercial Dialogue, honoring the commitment of President Bush and Indian Prime Minister Manmohan Singh to revitalize bilateral trade discussions.

This is a great opportunity to get access to IndiaÂ’s high-level business, industry, and government representatives and opportunities to gain timely insights into the countryÂ’s trade and investment climate.

We strongly recommend and encourage you participate and benefit from this important business mission to India.

For details please visit India Mission

The New York Society of Security Analysts in association with USA-India Chamber of Commerce presents ‘Investing in Asia’ conference.

Date: Thursday, September 28, 2006

Time: 8:30 a.m.-5:00 p.m.

Location: NYSSA, 1177 Avenue of the Americas, 2nd floor
          (between 45th and 46th Streets), New York, NY 10036
          Photo ID required for access to the building.

Credit: PD/CE/CPE = 1

Asia has become a crucial part of the global economy, boasting three of the ten largest economies—China, Japan, and India—and contributing more than 35% of world GDP. Investment has been booming in recent years, with Asia accounting for about 40% of net private capital flows into emerging markets.

The region’s economy is now the fastest growing in the world, and contributes close to 50% of global growth. Aggregate GDP for Asia expanded by a robust 7.4% in 2005. This growth has been supported by a favorable external environment and continuing progress on domestic reform issues. Experts expect China and India to continue to be the fastest-growing countries in the region, with projected 2006 GDPs of 9.5% and 7.3%, respectively.

Where are the next best investment opportunities in Asia? Hear from the senior executives of growing public companies from the region, and learn what leading experts have to say about AsiaÂ’s economic outlook.

USA-India Chamber of Commerce presents Business Lunch Roundtable with David Bohigian, Assistant Secretary, International Trade Administration, U.S. Department of Commerce.

Program

Opening Remarks: Karun Rishi, President, USA-India Chamber of Commerce
Introduction: Nigel Thompson, Executive Director, Merck
Business Roundtable with David Bohigian, Assistant Secretary, U.S. Department of Commerce
Closing Remarks: Michael Fondo, Director, Fidelity Investments

Date: Tuesday, May 2, 2006.
Time: 12 pm - 2 pm

Location: Fairmont Copley Plaza Hotel, Boston

Assistant Secretary BohigianÂ’s Market Access and Compliance (MAC) division identifies and overcomes trade barriers, resolves trade policy issues, and ensures that our trading partners fully meet their obligations under our trade agreements. MAC ensures access to world markets for American companies.

MAC focuses on issues such as: Intellectual Property and Piracy, Quotas, Standards, Customs, Transparency and Contract Sanctity, National Treatment and Good Governance.

This roundtable is only for senior executives.

Event is complementary for members.

Annual International Business Forum and Networking Evening

Date: Tuesday, May 2, 2006.
Registration & Seminars: 2:30 pm - 6:00 pm
Networking reception: 6:30 pm - 8:00 pm
Location: One Financial Center, Boston, MA 02111

The Global Economic Outlook: Implications for International Business in the Year Ahead: Christopher Probyn, Chief International Economist, State Street Corporation

Keynote speaker: David Bohigian, Assistant Secretary, US Department of Commerce Panel discussion: Assessing & Managing Risk in the Global Marketplace

The business forum will kick off with a Global Economic Outlook seminar, which will include information on global market indicators and implications for international business in the year ahead. The forum will also include a session on Assessing and Managing Risk in the Global Marketplace, featuring panelists who will discuss techniques for assessing and mitigating various risks of doing business internationally: global security; political, economic and credit risk; intellectual property protection and commercial risks; and regulatory compliance.

Interactive lunch meeting with Dr. V.S.Seshadri, Minister (Commerce), Embassy of India

Date: Tuesday, March 14, 2006
Time: 11-45 am to 1-30 pm
Location: Downtown Boston

USA-India Chamber of Commerce presents an interactive lunch meeting with Dr. V.S.Seshadri, Minister (Commerce), Embassy of India, Washington DC. He is a senior diplomat and a key person responsible for trade and exim policy issues. He is also an expert on WTO issues. This will be the first briefing nationally discussing the trade agreements signed last week during President Bush's India visit.

Agenda:

USA-India Chamber of Commerce and USIBC present an Executive Luncheon Business Roundtable with Satwant Reddy, Secretary to Government of India, Ministry of Chemicals. She is the top ranking official in the ministry. Her portfolio includes the regulation of all state-owned chemical companies, pharmaceuticals, and petrochemicals. Among other things, she is tasked responsibility for formulating India ’s data exclusivity and pharmaceutical price control policies

Date: January 27, 2006
Time: 11-30 AM to 2 PM
Location: Downtown Boston

It is a member’s only event for senior executives. This event is complementary for our members.

Please email to info@usaindiachamber.org if you are interested in attending.

Jan 26, 2006, 6-30 pm

Dinner meeting with Ms. Satwant Reddy, Secretary to Government of India, Ministry of Chemicals & Petrochemicals and Prof. Josh Lerner, Jacob H. Schiff Professor of Investment Banking, Harvard Business School and author of the book: 'Innovation and Its Discontents’: How Our Broken Patent System is Endangering Innovation and Progress. Exclusively for members and sponsors.

This roundtable is only for senior executives.

Event is complementary for members.